TP53 and cancer: In addition, a common effect of WDR5 depletion across different cancer models (covering SS, leukemia, and pancreatic cancer) (26) is deregulation of RP-coding genes, leading to activation of P53 signaling, consistent with prior studies using other tumor models (26, 39, 40).